Your search returned 10 results.

Results
	1.	Response to concerns over Cantillon et al. dopamine serotonin stabilizer RP5063 clinical trial's design, analyses and findings (SCHRES-D-17-00455) by Ahmed S Aboraya, MD, DrPh. [electronic resource] by Cantillon, Marc Bhat, Laxminarayan Producer: 20181211 In: Schizophrenia research vol. 195 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	2.	Pharmacokinetics of RP5063 Following Single Doses to Normal Healthy Volunteers and Multiple Doses Over 10 Days to Stable Schizophrenic Patients. [electronic resource] by Cantillon, Marc Ings, Robert Bhat, Laxminarayan Producer: 20190715 In: Clinical and translational science vol. 11 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	3.	Initial Clinical Experience of RP5063 Following Single Doses in Normal Healthy Volunteers and Multiple Doses in Patients with Stable Schizophrenia. [electronic resource] by Cantillon, Marc Ings, Robert Bhat, Laxminarayan Producer: 20190715 In: Clinical and translational science vol. 11 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	4.	A Population Pharmacokinetic and Pharmacodynamic Analysis of RP5063 Phase 2 Study Data in Patients with Schizophrenia or Schizoaffective Disorder. [electronic resource] by Cantillon, Marc Ings, Robert Prakash, Arul Bhat, Laxminarayan Producer: 20190117 In: European journal of drug metabolism and pharmacokinetics vol. 43 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	5.	Dopamine serotonin stabilizer RP5063: A randomized, double-blind, placebo-controlled multicenter trial of safety and efficacy in exacerbation of schizophrenia or schizoaffective disorder. [electronic resource] by Cantillon, Marc Prakash, Arul Alexander, Ajay Ings, Robert Sweitzer, Dennis Bhat, Laxminarayan Producer: 20180724 In: Schizophrenia research vol. 189 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	6.	Synthesis and biological evaluation of novel steroidal pyrazoles as substrates for bile acid transporters. [electronic resource] by Bhat, Laxminarayan Jandeleit, Bernd Dias, Tracy M Moors, Tristen L Gallop, Mark A Producer: 20050502 In: Bioorganic & medicinal chemistry letters vol. 15 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	7.	RP5063, an atypical antipsychotic drug with a unique pharmacologic profile, improves declarative memory and psychosis in mouse models of schizophrenia. [electronic resource] by Rajagopal, Lakshmi Kwon, Sunoh Huang, Mei Michael, Eric Bhat, Laxminarayan Cantillon, Marc Meltzer, Herbert Y Producer: 20171212 In: Behavioural brain research vol. 332 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	8.	RP5063, a novel, multimodal, serotonin receptor modulator, prevents Sugen 5416-hypoxia-induced pulmonary arterial hypertension in rats. [electronic resource] by Bhat, Laxminarayan Hawkinson, Jon Cantillon, Marc Reddy, Dasharatha G Bhat, Seema R Laurent, Charles E Bouchard, Annie Biernat, Marzena Salvail, Dany Producer: 20180405 In: European journal of pharmacology vol. 810 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	9.	Evaluation of the effects of RP5063, a novel, multimodal, serotonin receptor modulator, as single-agent therapy and co-administrated with sildenafil, bosentan, and treprostinil in a monocrotaline-induced pulmonary arterial hypertension rat model. [electronic resource] by Bhat, Laxminarayan Hawkinson, Jon Cantillon, Marc Reddy, Dasharatha G Bhat, Seema R Laurent, Charles-E Bouchard, Annie Biernat, Marzena Salvail, Dany Producer: 20181009 In: European journal of pharmacology vol. 827 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	10.	RP5063, a novel, multimodal, serotonin receptor modulator, prevents monocrotaline-induced pulmonary arterial hypertension in rats. [electronic resource] by Bhat, Laxminarayan Hawkinson, Jon Cantillon, Marc Reddy, Dasharatha G Bhat, Seema R Laurent, Charles E Bouchard, Annie Biernat, Marzena Salvail, Dany Producer: 20180405 In: European journal of pharmacology vol. 810 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)